How
Patent situation

Patented molecular tube techniques will be transferred to create unique LabonaChip designs and medical systems. These systems will give a unique world position to the only European supply chain that has their own patent portfolio to sell prenatal diagnostics based on fetal DNA from maternal blood. The main competitors are USAbased companies.

 

SYSBioMaterial
reagents
Nano
          
Micro
          
SystemValidationDistribution
ANGELAB 1X Linked
(DNA Data)
Spinal Atrophy
(OSAKIDETZA)
FRS (Cystic Fibrosis)
Gaiker
(biodegradable Polymer)
(reagent storage)
Ademtech
(mag. Beads)
BTL
CAN
(QD for
q PCR)
Ikerlan
(sample prep on chip)
Osakidetza, DNAdata, Ademtech
(Sample prep in tube)
WUT
(Optical detector)
Ikerlan
(Design)
POC
(System exploitation)
BioDonostiaDNAData
ANGELAB 2CING &NIPD
(epigenetics based extraction)
Gaiker
(biodegradable Polymer)
Ademtech
(mag. Beads)
(reagent storage)
BTL
CAN
(QD for
q PCR)
Ikerlan
(sample prep on chip)
CING
(Sample prep in tube)
WUT
(Optical detector)
Ikerlan
(Design)
POC
(System exploitation)
CINGNIPD
ANGELAB 3CING

FRS, Osakidetza
(Cystic Fibrosis)
Gaiker
(biodegradable Polymer)
(reagent storage)
Ademtech
(mag. Beads)
BTL
CAN
(QD for
d PCR
HSG-IMIT
(Digital PCR)
Ikerlan
(Fluidics)
HSG-IMIT
(Digital PCR)
Biodonostia
CING
NIPD
DNAData
LPPLGaiker
(biodegradable Polymer)
(reagent storage)
BTL
Ikerlan
(Bonding)
HSG-IMIT
(Digital PCR)
EVG (Design)EVG
(Validation)
EVG

partners